Contract 75D30123P15844
Asuragen Incorporated · Department Of Health And Human Services · December 1, 2022
Asuragen Incorporated was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on December 1, 2022 for $75,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Austin, TX. It was awarded under full and open competition. It uses firm fixed-price contract pricing.
Contract details
- PIID
- 75D30123P15844
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
- Place of performance
- Austin, TX
- First action
- December 1, 2022
Description
ARMORED RNA
Modification timeline
-
December 1, 2022Base award$75.1K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $313.4K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $75.2K |
| Sysmex America, Inc | Department Of Health And Human Services | March 31, 2026 | $49.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | March 31, 2026 | $5.7K |
| Biomerieux Inc | Department Of Health And Human Services | March 31, 2026 | $0 |
| Beckman Coulter, Inc. | Department Of Health And Human Services | March 30, 2026 | $80.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75D30123P15844?
Contract 75D30123P15844 is a federal contract awarded to Asuragen Incorporated by Department Of Health And Human Services on December 1, 2022 for $75,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75D30123P15844?
Asuragen Incorporated won contract 75D30123P15844 from Department Of Health And Human Services.
How much is contract 75D30123P15844 worth?
Contract 75D30123P15844 has obligated $75,000 to date.